Genentech’s new treatment for wet AMD receives FDA approval
October 25, 2021
Susvimo's new therapeutic approach for wet AMD may help patients maintain their vision with as few as 2 treatments per year
© 2021 MJH Life Sciences™ and Optometry Times. All rights reserved.
FDA approves Bausch + Lomb and Clearside’s XIPERE for macular edema
October 25, 2021
The FDA has approved XIPERE for the treatment of macular edema associated with uveitis
Dry AMD: The Benefits of Remote Monitoring
October 25, 2021
How data from remote monitoring centers create better opportunities for treating patients with dry age-related macular degeneration.